We are live on ! Find out more
FEED

ENVUE MEDICAL INC NEW
FEED

Delisted

FEED was delisted on the 15th of September, 2026.

Back to rankings

8 hedge funds and large institutions have $215K invested in ENVUE MEDICAL INC NEW in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

1.71% less ownership

Funds ownership: 14.78% → 13.07% (-1.7%)

14% less capital invested

Capital invested by funds: $251K → $215K (-$36.2K)

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$24.3K
2
Citadel Advisors
Citadel Advisors
Florida
+$12.1K
3
VF
Virtu Financial
New York
+$12.1K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$55K
2
Renaissance Technologies
Renaissance Technologies
New York
-$16.3K
3
TSS
Two Sigma Securities
New York
-$6.48K

FEED Hedge Fund Activity: Q4 2024 in Review

8 of the 7,608 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q4 2024, worth a combined $215K — down 14% from $251K a quarter earlier.

Fund positioning in FEED was balanced in Q4 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, adding an estimated $24.3K. The largest seller was Armistice Capital, cutting an estimated $55K.

  • 8 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $215K of ENVUE MEDICAL INC NEW stock for Q4 2024, down 14% quarter-over-quarter.
  • 1 fund opened new ENVUE MEDICAL INC NEW positions in Q4 2024 and 1 closed out, a net change of 0 holders.
  • The largest ENVUE MEDICAL INC NEW buyer in Q4 2024 was UBS Group, an estimated $24.3K added.
  • The largest ENVUE MEDICAL INC NEW seller in Q4 2024 was Armistice Capital, an estimated $55K sold.

Based on aggregated 13F filings for Q4 2024.